• Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)

    Source: Buzz FX / 23 Dec 2024 09:36:12   America/New_York


    Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND) Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) 's stock had its "buy" rating restated
    Read more...
Share on,